{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1070870839834904321.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@language":"en","@value":"Kihara Masao"}]}],"career":[{"institution":{"notation":[{"@value":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}]}},{"institution":{"notation":[{"@value":"Joint Research Team from the Japanese Society of Nephrology and the Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan, Special Study Group for IgA Nephropathy, Tokyo, Japan"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360023720970130304","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.34067/kid.0000000000000498"},{"@type":"URI","@value":"https://journals.lww.com/10.34067/KID.0000000000000498"},{"@type":"URI","@value":"https://marianna-u.repo.nii.ac.jp/records/2001052"}],"notation":[{"@value":"Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:07523:0006949192_7LEqHz2wsOrRdZ10UCpO3Z1NDBQ"},{"@type":"CROSSREF","@value":"10.34067/kid.0000000000000498_EX4kIXVM2uH2Yl35yNFAQe8kBkA"},{"@type":"OPENAIRE","@value":"doi_dedup___::c22e67bd00cc71596568858648b0a384_EX4kIXVM2uH2Yl35yNFAQe8kBkA"}]}